UBS AM’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.4M Sell
1,371,531
-410,628
-23% -$7.31M ﹤0.01% 971
2025
Q1
$31.8M Buy
1,782,159
+1,080,514
+154% +$19.3M 0.01% 785
2024
Q4
$20.9M Sell
701,645
-206,354
-23% -$6.15M ﹤0.01% 927
2024
Q3
$14.2M Buy
907,999
+84,606
+10% +$1.32M ﹤0.01% 1080
2024
Q2
$14.1M Buy
823,393
+688,510
+510% +$11.8M ﹤0.01% 998
2024
Q1
$2.11M Buy
134,883
+6,011
+5% +$94K ﹤0.01% 1668
2023
Q4
$1.92M Buy
128,872
+10,042
+8% +$150K ﹤0.01% 1713
2023
Q3
$1.92M Sell
118,830
-307,608
-72% -$4.97M ﹤0.01% 1648
2023
Q2
$25.6M Hold
426,438
0.01% 709
2023
Q1
$25.6M Sell
426,438
-7,942
-2% -$478K 0.01% 709
2022
Q4
$31.9M Buy
434,380
+29,102
+7% +$2.13M 0.02% 652
2022
Q3
$30.8M Sell
405,278
-25,542
-6% -$1.94M 0.02% 662
2022
Q2
$29.9M Buy
430,820
+118,577
+38% +$8.24M 0.02% 651
2022
Q1
$25.9M Sell
312,243
-15,028
-5% -$1.25M 0.01% 770
2021
Q4
$24.6M Buy
327,271
+12,510
+4% +$939K 0.01% 850
2021
Q3
$36.6M Buy
314,761
+745
+0.2% +$86.5K 0.02% 717
2021
Q2
$69.7M Buy
314,016
+31,106
+11% +$6.9M 0.03% 549
2021
Q1
$37.4M Buy
282,910
+60,631
+27% +$8.01M 0.02% 693
2020
Q4
$38.5M Buy
222,279
+112,421
+102% +$19.5M 0.02% 671
2020
Q3
$12.2M Buy
109,858
+9,902
+10% +$1.1M 0.01% 886
2020
Q2
$5.93M Sell
99,956
-119,148
-54% -$7.07M ﹤0.01% 1053
2020
Q1
$14.8M Sell
219,104
-22,470
-9% -$1.51M 0.01% 759
2019
Q4
$20.4M Sell
241,574
-108,486
-31% -$9.14M 0.01% 772
2019
Q3
$26.2M Buy
350,060
+5,197
+2% +$389K 0.02% 692
2019
Q2
$21.8M Buy
344,863
+1,064
+0.3% +$67.3K 0.02% 737
2019
Q1
$16.6M Sell
343,799
-32,732
-9% -$1.58M 0.01% 785
2018
Q4
$12.6M Sell
376,531
-55,499
-13% -$1.86M 0.01% 811
2018
Q3
$22.6M Buy
432,030
+19,077
+5% +$1,000K 0.02% 719
2018
Q2
$12.9M Buy
+412,953
New +$12.9M 0.01% 883